S. 369: A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. S. 369: Preserve Access to Affordable Generics Act Sponsor introductory remarks on measure. (CR S1433) 2009-02-03 Read twice and referred to the Committee on the Judiciary. 2009-02-03 Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. 2009-10-15 Committee on the Judiciary. Reported by Senator Leahy with an amendment in the nature of a substitute. Without written report. 2009-10-15 Placed on Senate Legislative Calendar under General Orders. Calendar No. 183. 2009-10-15 By Senator Leahy from Committee on the Judiciary filed written report. Report No. 111-123. Minority views filed. 2010-02-02 S. 369: Preserve Access to Affordable Generics Act s S. 369: Preserve Access to Affordable Generics Act (111th Congress) Preserve Access to Affordable Generics Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. Prescription drugs Administrative law and regulatory procedures Marketing and advertising Competition and antitrust Intellectual property Commerce Federal Trade Commission (FTC) Contracts and agency 2009-02-03 111 2009-02-03 369 calendar SenateBill LegislativeAction OfficialTitle ShortTitle